Stock listing
Entrada Therapeutics, Inc.
Selected listing: TRDA · NASDAQ · USD · US
Entrada Therapeutics, Inc. (NASDAQ:TRDA), Health Technology. Latest release Sep 10, 2026: Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS…
- Ticker
- NASDAQ:TRDA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. is a public company traded under the ticker TRDA in the American market. Entrada focuses on developing innovative therapies for serious diseases, leveraging its proprietary platform to advance its drug candidates.
Latest news from Entrada Therapeutics, Inc.
Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program
September 10, 2026
Entrada Therapeutics Reports Second Quarter 2026 Financial Results
August 5, 2026
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study
June 2, 2026
Entrada Therapeutics Announces Positive Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study
May 7, 2026
Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026
May 6, 2026
Research Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. company profile
View the public company page for Entrada Therapeutics, Inc. on 6ix.
Entrada Therapeutics, Inc. news
Read company news and market updates connected to Entrada Therapeutics, Inc..
Entrada Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Entrada Therapeutics, Inc..